ID   ELOV7_RAT               Reviewed;         281 AA.
AC   D4ADY9;
DT   18-APR-2012, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 1.
DT   24-JUL-2024, entry version 75.
DE   RecName: Full=Very long chain fatty acid elongase 7 {ECO:0000255|HAMAP-Rule:MF_03207};
DE            EC=2.3.1.199 {ECO:0000250|UniProtKB:A1L3X0, ECO:0000255|HAMAP-Rule:MF_03207};
DE   AltName: Full=3-keto acyl-CoA synthase Elovl7 {ECO:0000255|HAMAP-Rule:MF_03207};
DE   AltName: Full=ELOVL fatty acid elongase 7 {ECO:0000255|HAMAP-Rule:MF_03207};
DE            Short=ELOVL FA elongase 7 {ECO:0000255|HAMAP-Rule:MF_03207};
DE   AltName: Full=Elongation of very long chain fatty acids protein 7 {ECO:0000255|HAMAP-Rule:MF_03207};
DE   AltName: Full=Very long chain 3-ketoacyl-CoA synthase 7 {ECO:0000255|HAMAP-Rule:MF_03207};
DE   AltName: Full=Very long chain 3-oxoacyl-CoA synthase 7 {ECO:0000255|HAMAP-Rule:MF_03207};
GN   Name=Elovl7 {ECO:0000255|HAMAP-Rule:MF_03207};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
CC   -!- FUNCTION: Catalyzes the first and rate-limiting reaction of the four
CC       reactions that constitute the long-chain fatty acids elongation cycle.
CC       This endoplasmic reticulum-bound enzymatic process allows the addition
CC       of 2 carbons to the chain of long- and very long-chain fatty acids
CC       (VLCFAs) per cycle. Condensing enzyme with higher activity toward C18
CC       acyl-CoAs, especially C18:3(n-3) acyl-CoAs and C18:3(n-6)-CoAs. Also
CC       active toward C20:4-, C18:0-, C18:1-, C18:2- and C16:0-CoAs, and weakly
CC       toward C20:0-CoA. Little or no activity toward C22:0-, C24:0-, or
CC       C26:0-CoAs. May participate in the production of saturated and
CC       polyunsaturated VLCFAs of different chain lengths that are involved in
CC       multiple biological processes as precursors of membrane lipids and
CC       lipid mediators. {ECO:0000255|HAMAP-Rule:MF_03207}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a very-long-chain acyl-CoA + H(+) + malonyl-CoA = a very-long-
CC         chain 3-oxoacyl-CoA + CO2 + CoA; Xref=Rhea:RHEA:32727,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57384, ChEBI:CHEBI:90725, ChEBI:CHEBI:90736;
CC         EC=2.3.1.199; Evidence={ECO:0000255|HAMAP-Rule:MF_03207};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:32728;
CC         Evidence={ECO:0000250|UniProtKB:A1L3X0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=eicosanoyl-CoA + H(+) + malonyl-CoA = 3-oxodocosanoyl-CoA +
CC         CO2 + CoA; Xref=Rhea:RHEA:35327, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16526, ChEBI:CHEBI:57287, ChEBI:CHEBI:57380,
CC         ChEBI:CHEBI:57384, ChEBI:CHEBI:71451;
CC         Evidence={ECO:0000250|UniProtKB:A1L3X0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35328;
CC         Evidence={ECO:0000250|UniProtKB:A1L3X0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + H(+) + malonyl-CoA =
CC         (7Z,10Z,13Z,16Z)-3-oxodocosatetraenoyl-CoA + CO2 + CoA;
CC         Xref=Rhea:RHEA:36475, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57368, ChEBI:CHEBI:57384,
CC         ChEBI:CHEBI:73852; Evidence={ECO:0000250|UniProtKB:A1L3X0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36476;
CC         Evidence={ECO:0000250|UniProtKB:A1L3X0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6Z,9Z,12Z)-octadecatrienoyl-CoA + H(+) + malonyl-CoA =
CC         (8Z,11Z,14Z)-3-oxoeicosatrienoyl-CoA + CO2 + CoA;
CC         Xref=Rhea:RHEA:35379, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57363, ChEBI:CHEBI:57384,
CC         ChEBI:CHEBI:71481; Evidence={ECO:0000250|UniProtKB:A1L3X0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35380;
CC         Evidence={ECO:0000250|UniProtKB:A1L3X0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoyl-CoA + H(+) + malonyl-CoA = (11Z,14Z)-
CC         3-oxoicosa-11,14-dienoyl-CoA + CO2 + CoA; Xref=Rhea:RHEA:36503,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57383, ChEBI:CHEBI:57384, ChEBI:CHEBI:74012;
CC         Evidence={ECO:0000250|UniProtKB:A1L3X0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36504;
CC         Evidence={ECO:0000250|UniProtKB:A1L3X0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + H(+) + malonyl-CoA = (11Z)-3-
CC         oxoicosenoyl-CoA + CO2 + CoA; Xref=Rhea:RHEA:36511,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57384, ChEBI:CHEBI:57387, ChEBI:CHEBI:74011;
CC         Evidence={ECO:0000250|UniProtKB:A1L3X0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36512;
CC         Evidence={ECO:0000250|UniProtKB:A1L3X0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + malonyl-CoA + octadecanoyl-CoA = 3-oxoeicosanoyl-CoA +
CC         CO2 + CoA; Xref=Rhea:RHEA:35319, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16526, ChEBI:CHEBI:57287, ChEBI:CHEBI:57384,
CC         ChEBI:CHEBI:57394, ChEBI:CHEBI:65115;
CC         Evidence={ECO:0000250|UniProtKB:A1L3X0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35320;
CC         Evidence={ECO:0000250|UniProtKB:A1L3X0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + hexadecanoyl-CoA + malonyl-CoA = 3-oxooctadecanoyl-CoA
CC         + CO2 + CoA; Xref=Rhea:RHEA:35315, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16526, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379,
CC         ChEBI:CHEBI:57384, ChEBI:CHEBI:71407;
CC         Evidence={ECO:0000250|UniProtKB:A1L3X0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35316;
CC         Evidence={ECO:0000250|UniProtKB:A1L3X0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z,15Z)-octadecatrienoyl-CoA + H(+) + malonyl-CoA =
CC         (11Z,14Z,17Z)-3-oxoeicosatrienoyl-CoA + CO2 + CoA;
CC         Xref=Rhea:RHEA:36523, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:74034,
CC         ChEBI:CHEBI:74054; Evidence={ECO:0000250|UniProtKB:A1L3X0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36524;
CC         Evidence={ECO:0000250|UniProtKB:A1L3X0};
CC   -!- PATHWAY: Lipid metabolism; fatty acid biosynthesis. {ECO:0000255|HAMAP-
CC       Rule:MF_03207}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:A1L3X0}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000255|HAMAP-Rule:MF_03207}; Multi-pass membrane protein
CC       {ECO:0000255|HAMAP-Rule:MF_03207}.
CC   -!- DOMAIN: The C-terminal di-lysine motif may confer endoplasmic reticulum
CC       localization. {ECO:0000255|HAMAP-Rule:MF_03207}.
CC   -!- SIMILARITY: Belongs to the ELO family. ELOVL7 subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03207}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   RefSeq; NP_001178773.1; NM_001191844.1.
DR   AlphaFoldDB; D4ADY9; -.
DR   SMR; D4ADY9; -.
DR   STRING; 10116.ENSRNOP00000014074; -.
DR   PhosphoSitePlus; D4ADY9; -.
DR   PaxDb; 10116-ENSRNOP00000014074; -.
DR   Ensembl; ENSRNOT00000014074.6; ENSRNOP00000014074.5; ENSRNOG00000010450.6.
DR   Ensembl; ENSRNOT00055019791; ENSRNOP00055015968; ENSRNOG00055011646.
DR   Ensembl; ENSRNOT00060006130; ENSRNOP00060004544; ENSRNOG00060003699.
DR   Ensembl; ENSRNOT00065035649; ENSRNOP00065028732; ENSRNOG00065020984.
DR   GeneID; 361895; -.
DR   KEGG; rno:361895; -.
DR   AGR; RGD:1310560; -.
DR   CTD; 79993; -.
DR   RGD; 1310560; Elovl7.
DR   eggNOG; KOG3071; Eukaryota.
DR   GeneTree; ENSGT01050000244838; -.
DR   InParanoid; D4ADY9; -.
DR   OMA; LPTLGMC; -.
DR   OrthoDB; 168669at2759; -.
DR   PhylomeDB; D4ADY9; -.
DR   TreeFam; TF323454; -.
DR   Reactome; R-RNO-75876; Synthesis of very long-chain fatty acyl-CoAs.
DR   UniPathway; UPA00094; -.
DR   PRO; PR:D4ADY9; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0009922; F:fatty acid elongase activity; ISO:RGD.
DR   GO; GO:0034625; P:fatty acid elongation, monounsaturated fatty acid; IBA:GO_Central.
DR   GO; GO:0034626; P:fatty acid elongation, polyunsaturated fatty acid; ISO:RGD.
DR   GO; GO:0019367; P:fatty acid elongation, saturated fatty acid; ISO:RGD.
DR   GO; GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006636; P:unsaturated fatty acid biosynthetic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0042761; P:very long-chain fatty acid biosynthetic process; ISO:RGD.
DR   HAMAP; MF_03207; VLCF_elongase_7; 1.
DR   InterPro; IPR030457; ELO_CS.
DR   InterPro; IPR002076; ELO_fam.
DR   InterPro; IPR033670; ELOVL7.
DR   PANTHER; PTHR11157:SF118; ELONGATION OF VERY LONG CHAIN FATTY ACIDS PROTEIN 7; 1.
DR   PANTHER; PTHR11157; FATTY ACID ACYL TRANSFERASE-RELATED; 1.
DR   Pfam; PF01151; ELO; 1.
DR   PROSITE; PS01188; ELO; 1.
PE   3: Inferred from homology;
KW   Acetylation; Disulfide bond; Endoplasmic reticulum;
KW   Fatty acid biosynthesis; Fatty acid metabolism; Lipid biosynthesis;
KW   Lipid metabolism; Membrane; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
FT   CHAIN           2..281
FT                   /note="Very long chain fatty acid elongase 7"
FT                   /id="PRO_0000416692"
FT   TOPO_DOM        2..27
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
FT   TRANSMEM        28..48
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03207"
FT   TOPO_DOM        49..72
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
FT   TRANSMEM        73..93
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03207"
FT   TOPO_DOM        94..115
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
FT   TRANSMEM        116..136
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03207"
FT   TOPO_DOM        137..142
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
FT   TRANSMEM        143..162
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03207"
FT   TOPO_DOM        163..176
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
FT   TRANSMEM        177..197
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03207"
FT   TOPO_DOM        198..206
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
FT   TRANSMEM        207..227
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03207"
FT   TOPO_DOM        228..236
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
FT   TRANSMEM        237..257
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03207"
FT   TOPO_DOM        258..281
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
FT   MOTIF           147..151
FT                   /note="HxxHH motif"
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
FT   MOTIF           277..281
FT                   /note="Di-lysine motif"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03207"
FT   ACT_SITE        150
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
FT   BINDING         124
FT                   /ligand="3-oxoeicosanoyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:65115"
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
FT   BINDING         137
FT                   /ligand="3-oxoeicosanoyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:65115"
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
FT   BINDING         139
FT                   /ligand="3-oxoeicosanoyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:65115"
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
FT   BINDING         142
FT                   /ligand="3-oxoeicosanoyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:65115"
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
FT   BINDING         147
FT                   /ligand="3-oxoeicosanoyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:65115"
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
FT   BINDING         187
FT                   /ligand="3-oxoeicosanoyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:65115"
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
FT   BINDING         204
FT                   /ligand="3-oxoeicosanoyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:65115"
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
FT   BINDING         208
FT                   /ligand="3-oxoeicosanoyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:65115"
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
FT   BINDING         211
FT                   /ligand="3-oxoeicosanoyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:65115"
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
FT   BINDING         266
FT                   /ligand="3-oxoeicosanoyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:65115"
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
FT   DISULFID        99..231
FT                   /evidence="ECO:0000250|UniProtKB:A1L3X0"
SQ   SEQUENCE   281 AA;  33547 MW;  A9314D85BF04B80C CRC64;
     MAFSDLTSRT VRFYDNWIKD ADPRVENWLL MSSPLPQTII LGLYVYFVTS LGPKLMENRK
     PFELKKAMIT YNFFIVLFSV YMCYEFVMSG WGTGYSFRCD IVDYSQSPRA MRMVHTCWLY
     YFSKFIELFD TIFFVLRKKN SQVTFLHVFH HTIMPWTWWF GVKFAAGGLG TFHALLNTAV
     HVVMYFYYGL CAMGPAYQKY LWWKKHLTSL QLVQFVLVTV HIGQIFFMED CNYQYPVFLY
     IIMSYGCIFL LLFLHFWYRA YTKGQRLPKT MENGNCKSKH H
//
